In 2007, Stanford Biodesign forged a first-of-its-kind partnership with the Government of India to seed and nurture a new health technology innovation ecosystem in the country. 32 fellows were trained between 2008 and 2015. They developed more than 20 new technologies and launched 12 startups.

Since then, the Stanford-India Biodesign (SIB) training model has been deployed at more than a dozen universities across India. 4000+ healthtech startups now operate in the country. And a vibrant ecosystem of founders convenes twice yearly to share knowledge and receive guidance on getting new technologies into the hands of patients.

Join us, on Wednesday February 26, to hear from two of the initiative's architects and an early alumna. How did they lay the groundwork for the program? What were the opportunities and challenges inherent in a collaboration with the government? How did the need for cost-effective technologies influence the innovation approach? And how did they catalyze the network of funders, suppliers, manufacturers, distributors, and purchasers required to get the inventions to patients.

We'll discuss their biggest takeaways from this entrepreneurial endeavor, the potential to replicate it in other resource-constrained environments, and what excites them most about the future of health technology innovation in India.